SEC Form D filing

OxyDial Inc, 2026-05-20

An SEC Form D private-offering notice from Philadelphia, PA, a $1,500,000 filer-stated offering target in Healthcare & health tech. Filed 2026-05-20. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

OxyDial Inc site↗ Verified via SEC Form D

Develops a portable oxygen hemoglobin equilibrium blood testing instrument for blood disorders such as sickle cell disease

Filed 2026-05-20Filed to raise $1,500,000First money in 2026-03-17Raised so far $700,000HQ (as filed) Philadelphia, PASector Healthcare & health tech web-verified against the company’s own siteStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified oxydial.com↗Named in the filing 4 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source